摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基-2-丙基(3-氟-2-吡啶基)氨基甲酸酯 | 603310-25-4

中文名称
2-甲基-2-丙基(3-氟-2-吡啶基)氨基甲酸酯
中文别名
——
英文名称
(3-fluoro-pyridin-2-yl)-carbamic acid tert-butyl ester
英文别名
N-[tert-butoxycarbonyl]-2-amino-3-fluoro-pyridine;tert-Butyl (3-fluoropyridin-2-yl)carbamate;tert-butyl N-(3-fluoropyridin-2-yl)carbamate
2-甲基-2-丙基(3-氟-2-吡啶基)氨基甲酸酯化学式
CAS
603310-25-4
化学式
C10H13FN2O2
mdl
——
分子量
212.224
InChiKey
SHMPLWCLJNZJLA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    51.2
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Purine derivatives as kinase inhibitors
    申请人:Engler Albert Thomas
    公开号:US20050090483A1
    公开(公告)日:2005-04-28
    The present invention provides kinase inhibitors of Formula I.
    本发明提供了式I的激酶抑制剂。
  • Urea Derivative
    申请人:Kurata Hitoshi
    公开号:US20070249620A1
    公开(公告)日:2007-10-25
    The present invention relates to a urea derivative or a pharmacologically acceptable salt thereof having an excellent DGAT inhibitory effect. A urea derivative having the formula: [wherein R 1 is a C 6 -C 10 aryl group which may be independently mono- to pentasubstituted by a group selected from Substituent Group a or others; R is a C 6 -C 10 aryl group which may be independently mono- to pentasubstituted by a group selected from Substituent Group a or others; E is a group having the formula (II) or the formula (III) (wherein R 3 is a hydrogen atom or others; R 4 and R 5 , which are the same or different, are a hydrogen atom or others; X and U, which are the same or different, are a group represented by the formula CH or others; m and n, which are the same or different, are I or another number) or others; and A is a group represented by the formula —NH—C(═O)— or others], or a pharmacologically acceptable salt thereof.
    本发明涉及一种具有出色DGAT抑制作用的脲衍生物或其药理学上可接受的盐。其中,该脲衍生物具有以下公式:[式中,R1是C6-C10芳基,可以独立地被来自置换基团a或其他的基团单独到五重取代;R是C6-C10芳基,可以独立地被来自置换基团a或其他的基团单独到五重取代;E是具有公式(II)或公式(III)的基团(其中,R3是氢原子或其他;R4和R5相同或不同,是氢原子或其他;X和U相同或不同,是由公式CH或其他表示的基团;m和n相同或不同,是I或其他数字)或其他;A是由公式—NH—C(═O)—或其他表示的基团],或其药理学上可接受的盐。
  • PURINE DERIVATIVES AS KINASE INHIBITORS
    申请人:Engler Thomas Albert
    公开号:US20090105229A1
    公开(公告)日:2009-04-23
    The present invention provides kinase inhibitors of Formula I.
    本发明提供了化合物I的激酶抑制剂。
  • UREA DERIVATIVE
    申请人:Sankyo Company, Limited
    公开号:EP1764360A1
    公开(公告)日:2007-03-21
    The present invention relates to a urea derivative or a pharmacologically acceptable salt thereof having an excellent DGAT inhibitory effect. A urea derivative having the formula: [wherein R1 is a C6-C10 aryl group which may be independently mono- to pentasubstituted by a group selected from Substituent Group a or others; R2 is a C6-C10 aryl group which may be independently mono- to pentasubstituted by a group selected from Substituent Group a or others; E is a group having the formula (II) or the formula (III) (wherein R3 is a hydrogen atom or others; R4 and R5, which are the same or different, are a hydrogen atom or others; X and U, which are the same or different, are a group represented by the formula CH or others; m and n, which are the same or different, are 1 or another number) or others; and A is a group represented by the formula -NH-C(=O)- or others], or a pharmacologically acceptable salt thereof.
    本发明涉及一种脲衍生物或其药理上可接受的盐,具有极佳的 DGAT 抑制作用。一种脲衍生物具有以下式子: [其中 R1 是 C6-C10 芳基,可独立地被选自取代基 a 或其它的基团一至五取代;R2 是 C6-C10 芳基,可独立地被选自取代基 a 或其它的基团一至五取代;E 是具有式(II)或式(III)的基团(其中 R3 是氢原子或其它;R4和R5相同或不同,为氢原子或其它;X和U相同或不同,为式CH代表的基团或其它;m和n相同或不同,为1或其它数字)或其它;以及A为式-NH-C(=O)-代表的基团或其它],或其药理学上可接受的盐。
  • A Multifunctional Reagent Designed for the Site-Selective Amination of Pyridines
    作者:Patrick S. Fier、Suhong Kim、Ryan D. Cohen
    DOI:10.1021/jacs.0c03537
    日期:2020.5.13
    We report the development of a multifunctional reagent for the direct conversion of pyridines to Boc-protected 2-aminopyridines with exquisite site selectivity and chemoselectivity. The novel reagent was prepared on 200-g scale in a single step, reacts in the title reaction under mild conditions without precautions toward air or moisture, and is tolerant of nearly all common functionality. Experimental and in situ spectroscopic monitoring techniques provide detailed insights and unexpected findings for the unique reaction mechanism.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-